Phase I clinical studies form an important foundation for drug development and eventual approval of life-saving therapies.
Founded by physicians committed to advancing medical science, Worldwide is out to change how the world sees CROs — in the best possible way. From Bioanalytical Sciences through Phase IIa trials, our Early Phase Services include a 300-bed clinical site in San Antonio, Texas that is GCP/ICH compliant.
Successful clinical development and commercialization of small molecules and biologics require that investigators, sponsors, and patients collaborate to preemptively facilitate study design, execution, and transition to commercialization.
Significant and ongoing research into IMID pathology and genetic links have led to the knowledge that underpinning these diseases is the dysregulation of the immune system, which leads to widespread and chronic inflammation.
Central Nervous System (CNS)
The common aims of early-phase research centre around helping to define the safety, tolerability and pharmacokinetics of a drug at single or multiple doses (or even multiple formulations) typically administered in an ascending manner.